The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Amino-terminal Truncation of Chemokines by CD26/Dipeptidyl-peptidase IV
Open accessAbstract
Chemokines are key players in inflammation and infection. Natural forms of the C-X-C chemokine granulocyte chemotactic protein-2 (GCP-2) and the C-C chemokine regulated on activation normal T cell expressed and secreted (RANTES), which miss two NH2-terminal residues, including a Pro in the penultimate position, have been isolated from leukocytes or tumor cells. In chemotaxis and intracellular calcium mobilization assays, the truncation caused a reduction in the specific activity of RANTES but not of GCP-2. The serine protease CD26/dipeptidyl-peptidase IV (CD26/DPP IV) could induce this observed NH2-terminal truncation of GCP-2 and RANTES but not that of the monocyte chemotactic proteins MCP-1, MCP-2 and MCP-3. No significant difference in neutrophil activation was detected between intact and CD26/DPP IV-truncated GCP-2. In contrast to intact natural RANTES(1-68), which still chemoattracts monocytes at 10 ng/ml, CD26/DPP IV-truncated RANTES(3-68) was inactive at 300 ng/ml and behaved as a natural chemotaxis inhibitor. Compared with intact RANTES, only a 10-fold higher concentration of RANTES(3-68) induced a significant Ca2+ response. Furthermore, RANTES(3-68) inhibited infection of mononuclear cells by an M-tropic HIV-1 strain 5-fold more efficiently than intact RANTES. Thus, proteolytic processing of RANTES by CD26/DPP IV may constitute an important regulatory mechanism during anti-inflammatory and antiviral responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
Grynkiewicz, G., Poenie, M., & Tsien, R. Y. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83641-4 · Cited by 21,607
Cocchi, F., DeVico, A. L., Garzino-Demo, A., Arya, S. K., Gallo, R. C., & Lusso, P. (1995) · Science · doi:10.1126/science.270.5243.1811 · Cited by 2,869
Baggiolini, M., Dewald, B., & Moser, B. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.675 · Cited by 2,192
Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
Schall, T. J., Bacon, K., Toy, K. J., & Goeddel, D. V. (1990) · Nature · doi:10.1038/347669a0 · Cited by 1,379
CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro
Wu, L., Paxton, W. A., Kassam, N., Ruffing, N., Rottman, J. B., Sullivan, N., Choe, H., Sodroski, J., Newman, W., Koup, R. A., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1681 · Cited by 694
Chemokine receptors: Gateways to inflammation and infection
Premack, B. A., & Schall, T. J. (1996) · Nature Medicine · doi:10.1038/nm1196-1174 · Cited by 630
Potent Inhibition of HIV-1 Infectivity in Macrophages and Lymphocytes by a Novel CCR5 Antagonist
Simmons, G., Clapham, P. R., Picard, L., Offord, R. E., Rosenkilde, M. M., Schwartz, T. W., Buser, R., Wells, T. N. C., & Proudfoot, A. E. I. (1997) · Science · doi:10.1126/science.276.5310.276 · Cited by 608
Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4
Schols, D., Struyf, S., Damme, J. V., Esté, J. A., Henson, G., & Clercq, E. D. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1383 · Cited by 554
Self-citationProline motifs in peptides and their biological processing
Vanhoof, G., Goossens, F., De Meester, I., Hendriks, D., & Scharpé, S. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.9.7601338 · Cited by 451
Self-citationClark-Lewis, I., Schumacher, C., Baggiolini, M., & Moser, B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54472-0 · Cited by 425
Proudfoot, A. E. I., Power, C. A., Hoogewerf, A. J., Montjovent, M.-O., Borlat, F., Offord, R. E., & Wells, T. N. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.5.2599 · Cited by 418
CD26: a surface protease involved in T-cell activation
Fleischer, B. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90316-6 · Cited by 325
Chemokine receptors: Structure, function and role in microbial pathogenesis
Murphy, P. (1996) · Cytokine & Growth Factor Reviews · doi:10.1016/1359-6101(96)00009-3 · Cited by 320
Chemokines and HIV–1 second receptors
D'Souza, M. P., & Harden, V. (1996) · Nature Medicine · doi:10.1038/nm1296-1293 · Cited by 300
HIV blocked by chemokine antagonist
Arenzana-Seisdedos, F., Virelizier, J.-L., Rousset, D., Clark-Lewis, I., Loetscher, P., Moser, B., & Baggiolini, M. (1996) · Nature · doi:10.1038/383400a0 · Cited by 281
Gong, J. H., & Clark-Lewis, I. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.631 · Cited by 273
T Cell Activation Antigen, CD26, as a Cofactor for Entry of HIV in CD4 + Cells
Callebaut, C., Krust, B., Jacotot, E., & Hovanessian, A. G. (1993) · Science · doi:10.1126/science.7903479 · Cited by 219
Proost, P., De Wolf-Peeters, C., Conings, R., Opdenakker, G., Billiau, A., & Van Damme, J. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.3.1000 · Cited by 196
Self-citationFrohman, L. A., Downs, T. R., Heimer, E. P., & Felix, A. M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114049 · Cited by 177
Chemokine-leukocyte interactions. The voodoo that they do so well
Taub, D. D. (1996) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)89237-4 · Cited by 165
Schön, E., Jahn, S., Kießig, S. T., Demuth, H., Neubert, K., Barth, A., von Baehr, R., & Ansorge, S. (1987) · European Journal of Immunology · doi:10.1002/eji.1830171222 · Cited by 150
RANTES and MCP-3 Antagonists Bind Multiple Chemokine Receptors
Gong, J.-H., Uguccioni, M., Dewald, B., Baggiolini, M., & Clark‐Lewis, I. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10521 · Cited by 146
Wuyts, A., Osselaer, N. V., Haelens, A., Samson, I., Herdewijn, P. A., Ben‐Baruch, A., Oppenheim, J. J., Proost, P., & Damme, J. V. (1997) · Biochemistry · doi:10.1021/bi961999z · Cited by 146
Self-citationHoffmann, T., Faust, J., Neubert, K., & ANSORGE, S. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81609-4 · Cited by 115
Korom, S., Meester, I. D., Stadlbauer, T. H. W., Chandraker, A. K., Schaub, M., Sayegh, M. H., Belyaev, A., Haemers, A., Scharp, S., & Kupiec‐Weglinski, J. W. (1997) · Transplantation · doi:10.1097/00007890-199705270-00021 · Cited by 109
Self-citationWalz, A., & Baggiolini, M. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92203-1 · Cited by 107
Damme, J. V., Rampart, M., Conings, R., Decock, B., Osselaer, N. V., Willems, J., & Billiau, A. (1990) · European Journal of Immunology · doi:10.1002/eji.1830200933 · Cited by 95
Involvement of dipeptidyl peptidase IV in anin vivoimmune response
Kubota, T., Flentke, G. R., Bachovchin, W. W., & Stollar, B. D. (1992) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1992.tb06931.x · Cited by 81
Proost, P., Wuyts, A., Conings, R., Lenaerts, J., Billiau, A., Opdenakker, G., & Damme, J. V. (1993) · Biochemistry · doi:10.1021/bi00089a037 · Cited by 79
Self-citationRole of CD26/dipeptidyl peptidase IV in human immunodeficiency virus type 1 infection and apoptosis.
Morimoto, C., Lord, C. I., Zhang, C., et al. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9960 · Cited by 69
Noso, N., Sticherling, M., Bartels, J., Mallet, A. I., Christophers, E., & Schröder, J. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.5.1946 · Cited by 61
Oravecz, T., Roderiquez, G., Koffi, J.-N. N., Wang, J., Ditto, M., Bou‐Habib, D. C., Lusso, P., & Norcross, M. A. (1995) · Nature Medicine · doi:10.1038/nm0995-919 · Cited by 51
Proost, P., Leuven, P. V., Wuyts, A., EBBERINK, R. H. M., Opdenakker, G., & Damme, J. V. (1995) · Cytokine · doi:10.1006/cyto.1995.1013 · Cited by 35
Self-citationPurification and Identification of Natural Chemokines
Proost, P., Wuyts, A., Conings, R., Lenaerts, J., Put, W., & Damme, J. V. (1996) · Methods · doi:10.1006/meth.1996.0082 · Cited by 30
Self-citation
Cited by
Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides
Mentlein, R. (1999) · Regulatory Peptides · doi:10.1016/s0167-0115(99)00089-0 · Cited by 1,272
Chemokines and Cell Migration in Secondary Lymphoid Organs
Cyster, J. G. (1999) · Science · doi:10.1126/science.286.5447.2098 · Cited by 1,031
Lambeir, A.-M., Durinx, C., Scharpé, S., & De Meester, I. (2003) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/713609354 · Cited by 955
Self-citationVan den Steen, P. E., Proost, P., Wuyts, A., Van Damme, J., & Opdenakker, G. (2000) · Blood · doi:10.1182/blood.v96.8.2673 · Cited by 680
Self-citationPark, J. E., Lenter, M. C., Zimmermann, R. N., Garin-Chesa, P., Old, L. J., & Rettig, W. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36505 · Cited by 586
Metadata
- Authors
- Proost, P., De Meester, I., Schols, D., Struyf, S., Lambeir, A.-M., Wuyts, A., Opdenakker, G., De Clercq, E., Scharpé, S., & Van Damme, J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1998-03
- Volume
- 273
- Issue
- 13
- Pages
- 7222-7227
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2005991858
- Cited by
- 264
- References
- 34
- FWCI
- 11.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.